These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18478051)

  • 41. Effect of high-fat meal intake on the pharmacokinetic profile of ivermectin in Japanese patients with scabies.
    Miyajima A; Hirota T; Sugioka A; Fukuzawa M; Sekine M; Yamamoto Y; Yoshimasu T; Kigure A; Anata T; Noguchi W; Akagi K; Komoda M
    J Dermatol; 2016 Sep; 43(9):1030-6. PubMed ID: 26918286
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18mg tablet in healthy adult volunteers.
    Muñoz J; Ballester MR; Antonijoan RM; Gich I; Rodríguez M; Colli E; Gold S; Krolewiecki AJ
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006020. PubMed ID: 29346388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ivermectin Pharmacokinetics, Metabolism, and Tissue/Egg Residue Profiles in Laying Hens.
    Moreno L; Dominguez P; Farias C; Canton L; Virkel G; Maté L; Ceballos L; Lanusse C; Alvarez L
    J Agric Food Chem; 2015 Dec; 63(47):10327-32. PubMed ID: 26553292
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
    Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W
    Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis.
    Turner SA; Maclean JD; Fleckenstein L; Greenaway C
    Am J Trop Med Hyg; 2005 Nov; 73(5):911-4. PubMed ID: 16282302
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of selamectin in dogs after topical application.
    Dupuy J; Derlon AL; Sutra JF; Cadiergues MC; Franc M; Alvinerie M
    Vet Res Commun; 2004 Jul; 28(5):407-13. PubMed ID: 15379435
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics and metabolism of eprinomectin in cats when administered in a novel topical combination of fipronil, (S)-methoprene, eprinomectin and praziquantel.
    Kvaternick V; Kellermann M; Knaus M; Rehbein S; Rosentel J
    Vet Parasitol; 2014 Apr; 202(1-2):2-9. PubMed ID: 24703069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serious limitations of the current strategy to control Soil-Transmitted Helminths and added value of Ivermectin/Albendazole mass administration: A population-based observational study in Cameroon.
    Djune-Yemeli L; Nana-Djeunga HC; Lenou-Nanga CG; Donfo-Azafack C; Domche A; Fossuo-Thotchum F; Niamsi-Emalio Y; Ntoumi F; Kamgno J
    PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008794. PubMed ID: 33141853
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Population Pharmacokinetic Modeling of Azithromycin Eyedrops in Tears Following Single-Dose Topical Administration in Healthy Volunteers.
    Wu F; Zhao X; Li X; Cui Y
    Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):371-378. PubMed ID: 30357610
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study.
    Gupta S; Banfield C; Kantesaria B; Marino M; Clement R; Affrime M; Batra V
    Clin Ther; 2001 Mar; 23(3):451-66. PubMed ID: 11318079
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Membrane-water partitioning, membrane permeability, and baseline toxicity of the parasiticides ivermectin, albendazole, and morantel.
    Escher BI; Berger C; Bramaz N; Kwon JH; Richter M; Tsinman O; Avdeef A
    Environ Toxicol Chem; 2008 Apr; 27(4):909-18. PubMed ID: 18333693
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A linear model for the pharmacokinetics of azithromycin in healthy volunteers.
    Ripa S; Ferrante L; Prenna M
    Chemotherapy; 1996; 42(6):402-9. PubMed ID: 8957574
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of a novel formulation of ivermectin after administration to goats.
    González A; Sahagun AM; Diez MJ; Fernandez N; Sierra M; Garcia JJ
    Am J Vet Res; 2006 Feb; 67(2):323-8. PubMed ID: 16454640
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Field trial assessment of ivermectin pharmacokinetics and efficacy against susceptible and resistant nematode populations in cattle.
    Canton C; Canton L; Domínguez MP; Moreno L; Lanusse C; Alvarez L; Ceballos L
    Vet Parasitol; 2018 May; 256():43-49. PubMed ID: 29887029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Case Report: Subcutaneous Ivermectin Pharmacokinetics in Disseminated
    Konecny P; Weatherall CJ; Adhikari S; Duflou J; Marjoniemi V; Pretorius CJ; McWhinney B
    Am J Trop Med Hyg; 2018 Dec; 99(6):1580-1582. PubMed ID: 30334520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of parasitism on the pharmacokinetic disposition of ivermectin in lambs.
    Pérez R; Palma C; Cabezas I; Araneda M; Rubilar L; Alvinerie M
    J Vet Med A Physiol Pathol Clin Med; 2006 Feb; 53(1):43-8. PubMed ID: 16411909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Population pharmacokinetics study of azithromycin oral formulations using NONMEM.
    Zhang XY; Wang YR; Zhang Q; Lu W
    Int J Clin Pharmacol Ther; 2010 Oct; 48(10):662-9. PubMed ID: 20875372
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fexofenadine in horses: pharmacokinetics, pharmacodynamics and effect of ivermectin pretreatment.
    Olsén L; Ingvast-Larsson C; Larsson P; Broström H; Bondesson U; Sundqvist M; Tjälve H
    J Vet Pharmacol Ther; 2006 Apr; 29(2):129-35. PubMed ID: 16515667
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The pharmacokinetics and drug-drug interactions of ivermectin in Aedes aegypti mosquitoes.
    Duthaler U; Weber M; Hofer L; Chaccour C; Maia M; Müller P; Krähenbühl S; Hammann F
    PLoS Pathog; 2021 Mar; 17(3):e1009382. PubMed ID: 33730100
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma pharmacokinetic profile of fluralaner (Bravecto™) and ivermectin following concurrent administration to dogs.
    Walther FM; Allan MJ; Roepke RK
    Parasit Vectors; 2015 Oct; 8():508. PubMed ID: 26438338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.